Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of “Buy” by Brokerages
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...
Boston Scientific (NYSE:BSX) Price Target Raised to $115.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...
Le Lézard15d
Interventional Oncology Market to Hit USD 4.24 Billion by 2029 with 9.0% CAGR | MarketsandMarketstm
The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...
Endovascular Today5d
Embolic Protection Devices
atherectomy and stenting procedures in the lower extremity arteries Boston Scientific Corporation FilterWire EZ Embolic Protection System Filter Distal Indicated for use as a guidewire and EPS to ...
Endovascular Today9d
Embolic Protection Devices
Cordis Angioguard RX Emboli Capture Guidewire System Filter Distal Indicated for use ... computerized axial tomography angiography or magnetic resonance angiography Boston Scientific Corporation ...
What’s Behind The 130% Rise In Boston Scientific Stock?
So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...